About
Convergence Partners is a European venture capital firm that invests in founders building high-impact companies in the healthcare sector with large unmet needs. The Convergence team actively drives the scale-up and internationalisation of its portfolio companies to Germany, China, the US, and India.
We are interested in hearing from innovative EU HealthTech companies that have commercialised their technologies and are looking to accelerate scale-up.
Key Investment Selection Criteria
- B2B-focused HealthTech company with strong
international growth potential and ambitions - Highly scalable, IP-driven business model
- Commercialised product with first revenues
Typical Deal Structure
- Significant equity minority stake
- Ticket size up to EUR 5M initially - additional capital
reserved for follow-on investments - Board representation to support management
teams as an active sparring partner
Healthcare & Life SciencesVenture Capital & Private Equity
Investment criteria
Pre-seed
—
Seed
—
Series A
Invests
Series B
Invests
Growth
Invests
- Sectors
- Healthcare & Life SciencesVenture Capital & Private Equity
- Geographies
- China · Germany · India · Switzerland · United States
- Round role
- Leads and co-leads rounds
Highlights
Highlights coming soon
Notable work and milestones will show up here.
